AMAG Pharmaceuticals Ret. on equity
What is the Ret. on equity of AMAG Pharmaceuticals?
The Ret. on equity of AMAG Pharmaceuticals, Inc. is -86.41%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Health Care sector on NASDAQ compared to AMAG Pharmaceuticals
What does AMAG Pharmaceuticals do?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Companies with ret. on equity similar to AMAG Pharmaceuticals
- Impact Acquisitions has Ret. on equity of -86.58%
- Copper Lake Resources has Ret. on equity of -86.55%
- Pluri Inc has Ret. on equity of -86.55%
- Sinclair Inc has Ret. on equity of -86.53%
- Philip Morris International Inc has Ret. on equity of -86.50%
- Conformis has Ret. on equity of -86.46%
- AMAG Pharmaceuticals has Ret. on equity of -86.41%
- CASI Pharmaceuticals Inc has Ret. on equity of -86.36%
- co.don AG has Ret. on equity of -86.35%
- Amesite has Ret. on equity of -86.29%
- MeiraGTx plc has Ret. on equity of -86.28%
- MAX21 AG has Ret. on equity of -86.26%
- Lakshmi Precision Screws has Ret. on equity of -86.24%